BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Policy

  Health Canada approves TRESIBA® for children with Type 1 diabetes

  Rates of Type 1 diabetes among children and youth on the rise globally

  October 1, 2018

   · 

  4 min read
• Policy

  Specialty Enzymes & Probiotics Receives Coveted NSF GMP Certification

  Company is one of the first enzyme manufacturers to achieve esteemed NSF International Good Manufacturing Practices designation

  October 1, 2018

   · 

  2 min read
• Drug Development

  Blueprint Medicines Presents Foundational Preclinical Data Supporting the Development of BLU-782, a Highly Selective ALK2 Inhibitor, for the Treatment of Patients with Fibrodysplasia Ossificans Progressiva

  Plan to Initiate Phase 1 Clinical Trial in Healthy Volunteers in First Quarter of 2019

  October 1, 2018

   · 

  7 min read
• Business

  Rockwell Medical Appoints VP, Strategic Accounts

  Rockwell Medical, Inc. announced that Anne Boardman has been appointed Vice President, Strategic Accounts, effective today, October 1, 2018.

  October 1, 2018

   · 

  4 min read
• Pharm Country

  Actinium Launches Iomab-ACT Program Offering Its Targeted, Chemo-Free, Lymphodepletion Technology as a Universal Solution to CAR-T Product Developers

  Iomab-ACT program provides a single dose, outpatient, targeted lymphodepletion technology with the potential to improve CAR-T access and outcomes

  October 1, 2018

   · 

  8 min read